1. Home
  2. PLUG vs TMDX Comparison

PLUG vs TMDX Comparison

Compare PLUG & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Plug Power Inc.

PLUG

Plug Power Inc.

HOLD

Current Price

$2.05

Market Cap

2.9B

Sector

Energy

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$76.51

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLUG
TMDX
Founded
1997
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.5B
IPO Year
1999
2019

Fundamental Metrics

Financial Performance
Metric
PLUG
TMDX
Price
$2.05
$76.51
Analyst Decision
Hold
Buy
Analyst Count
11
9
Target Price
$2.31
$148.22
AVG Volume (30 Days)
44.5M
778.5K
Earning Date
05-11-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
47.01
382.18
EPS
N/A
0.20
Revenue
$709,919,000.00
$605,494,000.00
Revenue This Year
$26.67
$24.25
Revenue Next Year
$8.09
$18.75
P/E Ratio
N/A
$378.73
Revenue Growth
12.90
37.13
52 Week Low
$1.40
$60.11
52 Week High
$4.58
$156.00

Technical Indicators

Market Signals
Indicator
PLUG
TMDX
Relative Strength Index (RSI) 36.79 54.20
Support Level $1.92 $64.87
Resistance Level $2.49 $79.60
Average True Range (ATR) 0.14 3.15
MACD 0.01 0.46
Stochastic Oscillator 36.00 66.51

Price Performance

Historical Comparison
PLUG
TMDX

About PLUG Plug Power Inc.

Plug Power Inc is building an end-to-end green hydrogen ecosystem, from production, storage, and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets, including material handling, e-mobility, power generation, and industrial applications.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: